Pure non-gestational ovarian choriocarcinoma

dc.contributor.author	Mutua, Irene
dc.contributor.author	Njoroge, Moses
dc.contributor.author	Inyangala, Dennis
dc.contributor.author	Mwende, Caroline
dc.contributor.author	Denver, Mariga
dc.contributor.author	Wairimu, Waweru
dc.contributor.author	Swaleh, Shahbal
dc.contributor.author	Mwika, Peter
dc.contributor.author	Kuria, Kihiko
dc.contributor.author	Osawa, Francis
dc.contributor.author	Joel, Lessan
dc.date.accessioned	2019-02-27T07:54:17Z
dc.date.available	2019-02-27T07:54:17Z
dc.date.issued	2019
dc.identifier.citation	DOI: 10.1016/j.epsc.2018.10.005	en_US
dc.identifier.uri	https://www.sciencedirect.com/science/article/pii/S2213576618302677
dc.identifier.uri	http://hdl.handle.net/11295/106427
dc.description.abstract	We present a case of a 9-year-old female child who we are managing for pure non-gestational ovarian choriocarcinoma at Kenyatta National Hospital. It is an extremely rare germ cell tumor and quite aggressive. Sub-total hysterectomy, bilateral salpingo-oophorectomy, partial omentectomy and appendicectomy was done. The child is currently undergoing adjuvant chemotherapy. Prognosis is however reported to be dismal.	en_US
dc.language.iso	en	en_US
dc.publisher	University of Nairobi	en_US
dc.rights	Attribution-NonCommercial-NoDerivs 3.0 United States	*
dc.rights.uri	http://creativecommons.org/licenses/by-nc-nd/3.0/us/	*
dc.subject	Pure non-gestational ovarian choriocarcinoma Germ cell tumor Chemotherapy	en_US
dc.title	Pure non-gestational ovarian choriocarcinoma	en_US
dc.type	Article	en_US

Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivs 3.0 United States